Hindustan Foods Ltd

Hindustan Foods Ltd

₹ 554 0.75%
23 May - close price
About

Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories

Key Points

Acquired by Van group[1] Hindustan Food Limited (HFL) started a joint venture between Glaxo Smith Kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd was acquired by Vanity Case India Pvt. Ltd., and the latter bought 74.45% of the paid-up share capital.

  • Market Cap 6,513 Cr.
  • Current Price 554
  • High / Low 686 / 422
  • Stock P/E 63.0
  • Book Value 72.5
  • Dividend Yield 0.00 %
  • ROCE 14.9 %
  • ROE 14.0 %
  • Face Value 2.00

Pros

  • Company has delivered good profit growth of 35.4% CAGR over last 5 years
  • Company's median sales growth is 43.6% of last 10 years

Cons

  • Stock is trading at 7.64 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
562 565 597 627 595 534 585 643 620 640 685 712 698
531 532 561 587 557 498 544 597 580 594 631 652 645
Operating Profit 31 33 36 40 38 36 41 46 40 46 54 60 53
OPM % 6% 6% 6% 6% 6% 7% 7% 7% 6% 7% 8% 8% 8%
1 1 1 1 2 1 2 2 5 5 5 4 5
Interest 4 6 7 7 7 7 8 10 13 12 12 11 12
Depreciation 6 7 7 7 7 8 8 9 13 12 11 11 11
Profit before tax 22 21 23 27 25 22 27 28 19 27 35 41 36
Tax % 34% 35% 26% 35% 36% 19% 19% 21% 14% 26% 26% 26% 25%
15 14 17 17 16 18 22 23 16 20 26 31 27
EPS in Rs 1.29 1.23 1.50 1.54 1.45 1.58 1.91 2.00 1.43 1.75 2.28 2.60 2.27
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 6m Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3 17 24 38 139 492 772 1,407 2,021 2,383 2,381 2,734
4 23 22 35 128 459 716 1,317 1,905 2,236 2,219 2,521
Operating Profit -0 -6 2 3 10 33 56 90 115 147 163 212
OPM % -15% -33% 9% 8% 7% 7% 7% 6% 6% 6% 7% 8%
0 11 0 0 1 1 1 3 5 5 10 19
Interest 1 2 1 1 1 8 11 19 20 27 38 47
Depreciation 0 1 1 1 1 7 11 19 24 29 39 45
Profit before tax -1 2 -0 1 9 18 35 54 77 96 96 139
Tax % 0% 0% -2,980% 19% 27% 35% 34% 28% 35% 33% 19% 26%
-1 2 1 1 6 12 23 39 50 65 78 103
EPS in Rs -0.53 1.00 0.58 0.10 0.97 1.76 2.14 3.71 4.44 5.72 6.83 8.79
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 66%
5 Years: 29%
3 Years: 11%
TTM: 15%
Compounded Profit Growth
10 Years: 45%
5 Years: 35%
3 Years: 27%
TTM: 32%
Stock Price CAGR
10 Years: 53%
5 Years: 41%
3 Years: 15%
1 Year: 12%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 16%
Last Year: 14%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 5 5 13 13 13 21 21 23 23 23 24
Reserves -9 -7 -5 19 24 51 166 235 285 349 605 829
18 11 13 5 34 100 165 219 274 347 508 510
6 8 7 13 46 102 188 265 305 358 402 496
Total Liabilities 20 17 19 50 118 266 540 741 886 1,076 1,537 1,858
8 9 9 9 39 133 250 308 396 402 593 546
CWIP 3 2 2 3 3 0 26 53 9 45 5 99
Investments 0 0 0 0 0 0 3 3 7 80 84 127
9 6 8 38 75 133 261 377 474 549 855 1,086
Total Assets 20 17 19 50 118 266 540 741 886 1,076 1,537 1,858

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
3 1 1 -5 -5 -5 17 73 54 102 48 82
-3 -1 -1 -14 -19 -40 -145 -91 -103 -167 -347 -118
-0 0 0 24 26 43 153 34 32 47 294 75
Net Cash Flow -0 0 0 5 2 -2 24 16 -17 -18 -6 39

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 390 47 56 66 76 32 18 13 13 13 15 18
Inventory Days 295 108 37 90 139 54 74 58 52 61 87 88
Days Payable 387 184 103 166 237 85 94 74 60 58 67 62
Cash Conversion Cycle 298 -29 -10 -10 -21 1 -2 -3 5 16 35 45
Working Capital Days 107 -9 13 36 51 6 11 16 25 27 55 70
ROCE % -6% 34% 8% 7% 19% 22% 18% 18% 18% 19% 14% 15%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Apr 2025
64.85% 64.85% 64.85% 64.85% 64.85% 64.85% 63.82% 63.82% 63.82% 62.22% 62.22% 62.22%
6.04% 6.57% 6.56% 6.59% 6.58% 6.70% 6.70% 3.02% 3.39% 5.45% 5.24% 5.24%
6.55% 6.55% 6.64% 6.58% 6.03% 5.96% 7.18% 13.43% 13.79% 14.06% 14.56% 14.56%
22.56% 22.04% 21.94% 22.00% 22.54% 22.50% 22.30% 19.73% 19.00% 18.27% 17.97% 17.97%
No. of Shareholders 50,57653,71160,48969,98880,58786,14785,36484,13679,84676,79473,82273,822

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls